EASL postpones ILC 2020 until August
13 March 2020 Given the ongoing developments with COVID-19, EASL has postponed the International Liver CongressTM (ILC 2020) that was scheduled for 15-19 April 2020 in London. Having reviewed the situation, and…
US Task Force issues recommendation on screening adults aged 18-79 for hepatitis C, no matter their risk
On 2 March 2020, the U.S. Preventive Services Task Force published a final recommendation statement on screening for hepatitis C virus (HCV) infection in adolescents and adults. It recommends screening all adults…
Journal of Hepatology call for papers on COVID-19
Following the initiative of other leading scientific journals, we believe that it is timely, important, and appropriate to share as soon as possible with our Journal of Hepatology readers all information available…
Joint Statement I Prevention at the heart of Europe’s Beating Cancer Plan
Europe’s Beating Cancer Plan needs a thorough prevention pillar to tackle challenges common to all non-communicable diseases (NCDs), reads a statement by 30+ health organisations. NCDs, such as cardiovascular disease, cancer, respiratory…
Experts discuss latest research and future of liver cancer
Over 600 delegates from 44 countries gathered in Prague at the EASL Liver Cancer Summit 2020 to discuss latest developments and the future of liver cancer research. Organised annually by EASL, the…
EASL Postgraduate course now available in Chinese, Japanese, Portuguese and Spanish
Every year, the EASL Postgraduate course highlights many clinical practice dilemmas and engages the audience with world-renowned experts on how to make the best management decisions to help patients with liver disease.…
EASL expresses deep sadness at the sudden passing of Prof. Fritz von Weizsäcker
EASL expresses deep sadness at the sudden passing of Prof. Fritz von Weizsäcker, who died on 19 November 2019 at the age of 59. Prof. von Weizsäcker was an expert for gastroenterology,…